Hikal Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
|
|
|
|
|
|
|
|
|
Particulars | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 | Mar '2020 |
---|---|---|---|---|---|
Debt-Equity Ratio | 0.67 | 0.65 | 0.64 | 0.72 | 0.83 |
Long Term Debt-Equity Ratio | 0.39 | 0.35 | 0.27 | 0.32 | 0.38 |
Current Ratio | 1.28 | 1.26 | 1.22 | 1.25 | 1.28 |
Fixed Assets | 1.06 | 1.37 | 1.54 | 1.57 | 1.49 |
Inventory | 5.75 | 6.27 | 6.52 | 5.94 | 4.45 |
Debtors | 3.60 | 4.60 | 4.21 | 4.17 | 4.37 |
Interest Cover Ratio | 2.69 | 3.19 | 8.00 | 6.70 | 3.71 |
PBIDTM (%) | 15.10 | 12.97 | 17.78 | 19.06 | 18.38 |
PBITM (%) | 8.51 | 7.59 | 12.86 | 14.10 | 12.91 |
PBDTM (%) | 11.94 | 10.60 | 16.18 | 16.95 | 14.90 |
CPM (%) | 10.49 | 9.26 | 13.19 | 12.69 | 11.76 |
APATM (%) | 3.89 | 3.87 | 8.26 | 7.74 | 6.29 |
ROCE (%) | 7.51 | 8.20 | 14.86 | 15.93 | 13.35 |
RONW (%) | 5.99 | 7.12 | 16.04 | 15.22 | 12.06 |